ROSISTER® DUO

Prevention of Cardiovascular Complications

As adjunctive therapy to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease (CHD) and a history of acute coronary syndrome (ACS), in whom adequate disease control is achieved by the concomitant use of rosuvastatin and ezetimibe as single-component drugs at the same doses as in the combination drug.

Primary hypercholesterolemia/homozygous familial hypercholesterolemia

As adjunctive therapy to diet or other nonpharmacological measures (e.g., exercise, weight reduction) for the treatment of adult patients with primary (heterozygous familial and non-familial) hypercholesterolemia or homozygous familial hypercholesterolemia, in whom adequate disease control is achieved by the concomitant use of rosuvastatin and ezetimibe as single-component preparations at the same doses as in the combination preparation.